Prevention of infection after induced abortion

Contraception

Volumn 83, Issue 4, 2011, Pages 295-309

  Achilles, Sharon L ^a   Reeves, Matthew F ^a  

^a NONE

Author keywords

Antibiotic prophylaxis; Doxycycline; Induced abortion; Infection; Preventing infective complications

Indexed keywords

ANTIBIOTIC AGENT; CHLORHEXIDINE; PLACEBO; POVIDONE IODINE;

ACUTE DISEASE; ANTIBIOTIC PROPHYLAXIS; CHLAMYDIA TRACHOMATIS; FIRST TRIMESTER PREGNANCY; GENITAL TRACT INFECTION; HUMAN; INDUCED ABORTION; INFECTION RISK; INTRAUTERINE CONTRACEPTIVE DEVICE; MEDICAL ABORTION; NEISSERIA GONORRHOEAE; NONHUMAN; PREGNANCY; REVIEW; RISK FACTOR; SECOND TRIMESTER PREGNANCY; SURGICAL ABORTION; UTERINE CERVICITIS; VAGINITIS;

EID: 79952573648     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2010.11.006     Document Type: Article

References (78)

1. Finer LB, Henshaw SK. Abortion incidence and services in the United States in 2000. Perspect Sex Reprod Health 2003;35:6-15 (Evidence Grade: II-3).
2. Jones RK, Darroch JE, Henshaw SK. Patterns in the socioeconomic characteristics of women obtaining abortions in 2000-2001. Perspect Sex Reprod Health 2002;34:226-35 (Evidence Grade: II-3).
3. Gamble SB, Strauss LT, Parker WY, et al. Abortion surveillance- United States, 2005. Morb Mortal Wkly Rep Surveill Summ 2008;57:1-32 (Evidence Grade: II-3).
4. Paul M, Lichtenberg ES, Borgatta L, et al. A Clinician's Guide to Medical and Surgical Abortion. New York: Churchill Livingstone; 1999 (Evidence Grade: III).
5. Hakim-Elahi E, Tovell HM, Burnhill MS. Complications of firsttrimester abortion: a report of 170,000 cases. Obstet Gynecol 1990;76:129-35 (Evidence Grade: III).
6. Bartlett LA, Berg CJ, Shulman HB, et al. Risk factors for legal induced abortion-related mortality in the United States. Obstet Gynecol 2004;103:729-37 (Evidence Grade: II-2).
7. Sacks PC, Tchabo JG. Incidence of bacteremia at dilation and curettage. J Reprod Med 1992;37:331-4 (Evidence Grade: III).
8. Stubblefield PG, Grimes DA. Septic abortion. N Engl J Med 1994;331:310-4 (Evidence Grade: III).
9. Alekshun MN, Levy SB. Commensals upon us. Biochem Pharmacol 2006;71:893-900 (Evidence Grade: III).
10. Arias CA, Murray BE. Antibiotic-resistant bugs in the 21st century-a clinical super-challenge. N Engl J Med 2009;360:439-43 (Evidence Grade: III).
11. Ledger WJ. Prophylactic antibiotics in obstetrics-gynecology: a current asset, a future liability? Expert Rev Anti Infect Ther 2006;4:957-64 (Evidence Grade: III).
12. Hodgson JE. Major complications of 20,248 consecutive first trimester abortions: problems of fragmented care. Adv Plan Parent 1975;9:52-9 (Evidence Grade: II-3).
13. Wulff Jr GJ, Freiman SM. Elective abortion. Complications seen in a free-standing clinic. Obstet Gynecol 1977;49:351-7 (Evidence Grade: II-3).
14. Wadhera S. Early complication risks of legal abortions, Canada, 1975- 1980. Can J Public Health 1982;73:396-400 (Evidence Grade: II-3).
15. Frank PI, Kay CR, Lewis TL, Parish S. Outcome of pregnancy following induced abortion. Report from the joint study of the royal college of general practitioners and the royal college of obstetricians and gynaecologists. Br J Obstet Gynaecol 1985;92:308-16 (Evidence Grade: II-2).
16. Heisterberg L, Kringelbach M. Early complications after induced first-trimester abortion. Acta Obstet Gynecol Scand 1987;66:201-4 (Evidence Grade: III).
17. Fried G, Ostlund E, Ullberg C, et al. Somatic complications and contraceptive techniques following legal abortion. Acta Obstet Gynecol Scand 1989;68:515-21 (Evidence Grade: III).
18. Levallois P, Rioux JE. Prophylactic antibiotics for suction curettage abortion: results of a clinical controlled trial. Am J Obstet Gynecol 1988;158:100-5 (Evidence Grade: I).
19. Darj E, Stralin EB, Nilsson S. The prophylactic effect of doxycycline on postoperative infection rate after first-trimester abortion. Obstet Gynecol 1987;70:755-8 (Evidence Grade: I).
20. Brewer C. Prevention of infection after abortion with a supervised single dose of oral doxycycline. Br Med J 1980;281(6243):780-1 (Evidence Grade: II-1).
21. Henriques CU, Wilken-Jensen C, Thorsen P, et al. A randomised controlled trial of prophylaxis of post-abortal infection: ceftriaxone versus placebo. BJOG 1994;101:610-4 (Evidence Grade: I).
22. Krohn K. Investigation of the prophylactic effect of tinidazole on the postoperative infection rate of patients undergoing vacuum aspiration. Scand J Infect Dis Suppl 1981;26:101-3 (Evidence Grade: I).
23. Sonne-Holm S, Heisterberg L, Hebjoorn S, Dyring-Andersen K, Andersen JT, Hejl BL. Prophylactic antibiotics in first-trimester abortions: a clinical, controlled trial. Am J Obstet Gynecol 1981;139:693-6 (Evidence Grade: II-1).
24. Westrom L, Svensson L, Wolner-Hanssen P, Mardh PA. A clinical double-blind study on the effect of prophylactically administered single dose tinidazole on the occurrence of endometritis after first trimester legal abortion. Scand J Infect Dis Suppl 1981;26:104-9 (Evidence Grade: II-1).
25. Heisterberg L, Moller BR, Manthorpe T, Sorensen SS, Petersen K, Nielsen NC. Prophylaxis with lymecycline in induced first-trimester abortion: a clinical, controlled trial assessing the role of Chlamydia trachomatis and mycoplasma hominis. Sex Transm Dis 1985;12:72-5 (Evidence Grade: I).
26. Heisterberg L, Petersen K. Metronidazole prophylaxis in elective first trimester abortion. Obstet Gynecol 1985;65:371-4 (Evidence Grade: I).
27. Heisterberg L. Prophylactic antibiotics in women with a history of pelvic inflammatory disease undergoing first-trimester abortion. Acta Obstet Gynecol Scand 1987;66:15-8 (Evidence Grade: I).
28. Heisterberg L, Gnarpe H. Preventive lymecycline therapy in women with a history of pelvic inflammatory disease undergoing firsttrimester abortion: a clinical, controlled trial. Eur J Obstet Gynecol Reprod Biol 1988;28:241-7 (Evidence Grade: I).
29. Sorensen JL, Thranov I, Hoff G, Dirach J, Damsgaard MT. A doubleblind randomized study of the effect of erythromycin in preventing pelvic inflammatory disease after first trimester abortion. Br J Obstet Gynaecol 1992;99:434-8 (Evidence Grade: I).
30. Larsson PG, Platz-Christensen JJ, Thejls H, et al. Incidence of pelvic inflammatory disease after first-trimester legal abortion in women with bacterial vaginosis after treatment with metronidazole: a doubleblind, randomized study. Am J Obstet Gynecol 1992;166:100-3 (Evidence Grade: I).
31. Nielsen IK, Engdahl E, Larsen T. No effect of single dose ofloxacin on postoperative infection rate after first-trimester abortion. A clinical, controlled trial. Acta Obstet Gynecol Scand 1993;72:556-9 (Evidence Grade: II-1).
32. Grimes DA, Schulz KF. Morbidity and mortality from secondtrimester abortions. J Reprod Med 1985;30:505-14 (Evidence Grade: III).
33. Jacot FR, Poulin C, Bilodeau AP, et al. A five-year experience with second-trimester induced abortions: no increase in complication rate as compared to the first trimester. Am J Obstet Gynecol 1993;168:633-7 (Evidence Grade: II-2).
34. Peterson WF, Berry FN, Grace MR, et al. Second-trimester abortion by dilatation and evacuation: an analysis of 11,747 cases. Obstet Gynecol 1983;62:185-90 (Evidence Grade: III).
35. Altman AM, Stubblefield PG, Schlam JF, et al. Midtrimester abortion with Laminaria and vacuum evacuation on a teaching service. J Reprod Med 1985;30:601-6 (Evidence Grade: III).
36. Grossman D, Blanchard K, Blumenthal P. Complications after second trimester surgical and medical abortion. Reprod Health Matters 2008;16:173-82 (Evidence Grade: I).
37. Winkler CL, Gray SE, Hauth JC, et al. Mid-second-trimester labor induction: concentrated oxytocin compared with prostaglandin E2 vaginal suppositories. Obstet Gynecol 1991;77:297-300 (Evidence Grade: II-2).
38. Rakhshani R, Grimes DA. Prostaglandin E2 suppositories as a second-trimester abortifacient. J Reprod Med 1988;33:817-20 (Evidence Grade: III).
39. Jain JK, Mishell Jr DR. A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second-trimester pregnancy. N Engl J Med 1994;331:290-3 (Evidence Grade: I).
40. Grimes DA, Smith MS, Witham AD. Mifepristone and misoprostol versus dilation and evacuation for midtrimester abortion: a pilot randomised controlled trial. BJOG 2004;111:148-53 (Evidence Grade: I).
41. Autry AM, Hayes EC, Jacobson GF, et al. A comparison of medical induction and dilation and evacuation for second-trimester abortion. Am J Obstet Gynecol 2002;187:393-7 (Evidence Grade: II-2).
42. Hern WM. Laminaria versus Dilapan osmotic cervical dilators for outpatient dilation and evacuation abortion: randomized cohort comparison of 1001 patients. Am J Obstet Gynecol 1994;171:1324-8 (Evidence Grade: II-2).
43. Jonasson A, Larsson B, Bygdeman S, et al. The influence of cervical dilatation by laminaria tent and with Hegar dilators on the intrauterine microflora and the rate of postabortal pelvic inflammatory disease. Acta Obstet Gynecol Scand 1989;68:405-10 (Evidence Grade: I).
44. Skjeldestad FE, Tuveng J. Cervical dilatation with Lamicel in first trimester therapeutic abortion. Int J Gynaecol Obstet 1990;33:153-7 (Evidence Grade: I).
45. Wells EC, Hulka JF. Cervical dilation: a comparison of Lamicel and Dilapan.AmJ Obstet Gynecol 1989;161:1124-6 (Evidence Grade: I).
46. Evaldson GR, Fianu S, Jonasson A, et al. Does the hygroscopic property of the laminaria tent imply a risk for ascending infection in legal abortions? A microbiological study. Acta Obstet Gynecol Scand 1986;65:257-61 (Evidence Grade: III).
47. Bryman I, Granberg S, Norstrom A. Reduced incidence of postoperative endometritis by the use of Laminaria tents in connection with first trimester abortion. Acta Obstet Gynecol Scand 1988;67:323-5 (Evidence Grade: I).
48. Carbonell JL, Gallego FG, Llorente MP, et al. Vaginal vs. sublingual misoprostol with mifepristone for cervical priming in secondtrimester abortion by dilation and evacuation: a randomized clinical trial. Contraception 2007;75:230-7 (Evidence Grade: I).
49. Todd CS, Soler M, Castleman L, et al. Buccal misoprostol as cervical preparation for second trimester pregnancy termination. Contraception 2002;65:415-8 (Evidence Grade: II-3).
50. Castleman LD, Oanh KTH, Hyman AG, et al. Introduction of the dilation and evacuation procedure for second-trimester abortion in Vietnam using manual vacuum aspiration and buccal misoprostol. Contraception 2006;74:272-6 (Evidence Grade: III).
51. Edelman AB, Buckmaster JG, Goetsch MF, et al. Cervical preparation using laminaria with adjunctive buccal misoprostol before second-trimester dilation and evacuation procedures: A randomized clinical trial. Am J Obstet Gynecol 2006;194:425-30 (Evidence Grade: I).
52. Patel A, Talmont E, Morfesis J, et al. Adequacy and safety of buccal misoprostol for cervical preparation prior to termination of secondtrimester pregnancy. Contraception 2006;73:420-30 (Evidence Grade: II-3).
53. Creinin MD, Fox MC, Teal S, et al. A randomized comparison of misoprostol 6 to 8 hours versus 24 hours after mifepristone for abortion. Obstet Gynecol 2004;103:851-9 (Evidence Grade: I).
54. Creinin MD, Schreiber CA, Bednarek P, et al. Mifepristone and misoprostol administered simultaneously versus 24 hours apart for abortion: a randomized controlled trial. Obstet Gynecol 2007;109:885-94 (Evidence Grade: I).
55. Schaff EA, Eisinger SH, Stadalius LS, et al. Low-dose mifepristone 200 mg and vaginal misoprostol for abortion. Contraception 1999;59:1-6 (Evidence Grade: II-2).
56. Silvestre L, Dubois C, Renault M, et al. Voluntary interruption of pregnancy with mifepristone (RU 486) and a prostaglandin analogue. A large-scale French experience. N Engl J Med 1990;322:645-8 (Evidence Grade: II-2).
57. Spitz IM, Bardin CW, Benton L, et al. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med 1998;338:1241-7 (Evidence Grade: II-2).
58. Ulmann A, Silvestre L, Chemama L, et al. Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16,369 women. Acta Obstet Gynecol Scand 1992;71:278-83 (Evidence Grade: II-2).
59. Shannon C, Brothers LP, Philip NM, et al. Infection after medical abortion: a review of the literature. Contraception 2004;70:183-90 (Evidence Grade: I).
60. Henderson JT, Hwang AC, Harper CC, et al. Safety of mifepristone abortions in clinical use. Contraception 2005;72:175-8 (Evidence Grade: III).
61. Fjerstad M, Trussell J, Sivin I, et al. Rates of serious infection after changes in regimens for medical abortion. N Engl J Med 2009;361:145-51 (Evidence Grade: II-3).
62. Cohen AL, Bhatnagar J, Reagan S, et al. Toxic shock associated with Clostridium sordellii and Clostridium perfringens after medical and with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med 2003;163:972-8 (Evidence Grade: III).
63. Harbarth S, Samore MH, Lichtenberg D, et al. Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. Circulation 2000;101:2916-21 (Evidence Grade: III).
64. Namias N, Harvill S, Ball S, et al. Cost and morbidity associated with antibiotic prophylaxis in the ICU. J Am Coll Surg 1999;188:225-30 (Evidence Grade: II-3).
65. Reid G, Bruce AW, Cook RL, et al. Effect on urogenital flora of antibiotic therapy for urinary tract infection. Scand J Infect Dis 1990;22:43-7 (Evidence Grade: I).
66. Monif GR, Thompson JL, Stephens HD, et al. Quantitative and qualitative effects of povidone-iodine liquid and gel on the aerobic and anaerobic flora of the female genital tract. Am J Obstet Gynecol 1980;137:432-8 (Evidence Grade: II-3).
67. Osborne NG, Wright RC. Effect of preoperative scrub on the bacterial flora of the endocervix and vagina. Obstet Gynecol 1977;50:148-51 (Evidence Grade: II-3).
68. Culligan PJ, Kubik K, Murphy M, et al. A randomized trial that compared povidone iodine and chlorhexidine as antiseptics for vaginal hysterectomy. Am J Obstet Gynecol 2005;192:422-5 (Evidence Grade: I).
69. Lundh C, Meirik O, Nygren KG. Vaginal cleansing at vacuum aspiration abortion does not reduce the risk of postoperative infection. Acta Obstet Gynecol Scand 1983;62:275-7 (Evidence Grade: II-1).
70. Grimes D, Schulz K, Stanwood N. Immediate postabortal insertion of intrauterine devices. Cochrane Database Syst Rev 2002:CD001777 (Evidence Grade: I).
71. Anonymous. IUD insertion following termination of pregnancy: a clinical trial of the TCu 220C, Lippes loop D, and copper 7. Stud Fam Plann 1983;14:99-108 (Evidence Grade: I).
72. Pakarinen P, Toivonen J, Luukkainen T. Randomized comparison of levonorgestrel- and copper-releasing intrauterine systems immediately after abortion, with 5 years' follow-up. Contraception 2003;31- 34:68 (Evidence Grade: I).
73. Goldman JA, Dekel A, Reichman J. Immediate postabortion intrauterine contraception in nulliparous adolescents. Isr J Med Sci 1979;15:522-5 (Evidence Grade: II-2).
74. Drey EA, Reeves MF, Ogawa DD, et al. Insertion of intrauterine contraceptives immediately following first- and second-trimester abortions. Contraception 2009;79:397-402 (Evidence Grade: II-2).
75. Goodman S, Hendlish SK, Reeves MF, et al. Impact of immediate postabortal insertion of intrauterine contraception on repeat abortion. Contraception 2008;78:143-8 (Evidence Grade: II-2).
76. Goodman S, Hendlish SK, Benedict C, et al. Increasing intrauterine contraception use by reducing barriers to post-abortal and interval insertion. Contraception 2008;78:136-42 (Evidence Grade: II-3).
77. Hohmann HLRM, Chen BA, Perriera L, Hayes JL, Creinin MD. Immediate versus delayed insertion of the levonorgestrel-releasing intrauterine device following dilation and evacuation: a randomized controlled trial. Contraception 2009;80:209 (Evidence Grade: I).
78. Creinin MDRM, Cwiak CA, Espey E, Jensen JT. Immediate intrauterine device insertion following suction aspiration between 5-12 weeks of gestation increases rates of insertion and utilization compared to scheduled delayed insertion. Contraception 2009;80:203 (Evidence Grade: I).